| 2025-12-04 |
详情>>
股本变动：
变动后总股本30211.90万股
|
| 2025-11-19 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.2元,归母净利润-7.76亿元,同比去年增长56.15%
|
| 2025-11-19 |
财报披露：
美东时间 2025-11-19 盘前发布财报
|
| 2025-08-20 |
详情>>
业绩披露：
2025年中报每股收益-0.2元,归母净利润-7.71亿元,同比去年增长-8.25%
|
| 2025-05-28 |
详情>>
业绩披露：
2025年一季报每股收益-0.08元,归母净利润-3.14亿元,同比去年增长12.66%
|
| 2025-05-09 |
股东大会：
将于2025-06-09召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements of the Company for the year ended December 31, 2024 and the reports of the Directors and independent auditor thereon;
2.To re-elect Mr. Zou Tao as an executive Director;
3.To re-elect Mr. Lei Jun as a non-executive Director;
4.To re-elect Mr. Yu Mingto as an independent non-executive Director;
5.To re-elect Mr. Wang Hang as independent non-executive Director;
6.To authorize the Board to fix the remuneration of the Directors;
7.To re-appoint Ernst & Young as auditor of the Company to hold office until the conclusion of the next annual general meeting of the Company and to authorize the audit committee of the Board to fix their remuneration for the year ending December 31, 2025;
8.To give a general mandate to the Directors to issue, allot and deal with additional shares of the Company (the “Shares”) and/or American Depositary Shares of the Company (the “ADSs”), and/or sell and/or transfer Shares out of treasury that are held as treasury shares not exceeding 20% of the total number of issued Shares (excluding any treasury shares, if any) as at the date of passing this resolution (the “Issuance and Resale Mandate”);
9.To give a general mandate to the Directors to repurchase the Shares and/or ADSs not exceeding 10% of the total number of issued Shares (excluding any treasury shares, if any) as at the date of passing this resolution (the “Repurchase Mandate”);
10.Conditional upon the passing of resolutions no. 8 and no. 9, to extend the Issuance and Resale Mandate granted to the Directors to issue, allot and deal with additional Shares and/or ADSs, and/or sell and/or transfer Shares out of treasury that are held as treasury shares, in the capital of the Company by the aggregate number of the Shares and/or Shares underlying the ADSs repurchased by the Company under the Repurchase Mandate;
11.To approve, confirm and/or ratify:(a)the subscription agreement dated April 16, 2025 (the “Subscription Agreement”) entered into between the Company as the issuer and Kingsoft Corporation Limited as the subscriber (the “Subscriber”) in relation to the issue of 69,375,000 ordinary shares (the “Subscription Shares”) of the Company at the subscription price of HK$5.83 each and the transactions contemplated thereunder;
(b)the specific mandate to Directors which shall entitle the Directors to exercise all the powers of the Company to allot and issue the Subscription Shares to the Subscriber, on and subject to the terms and conditions of the Subscription Agreement entered into between the Company and the Subscriber;
(c)the authorization to any one of the Directors to do all such acts and things, to sign and execute such documents or agreements or deeds on behalf of the Company and to do such other things and to take all such actions as he/she considers necessary, appropriate, desirable and expedient for the purposes of giving effect to or in connection with the Subscription Agreement and the transactions contemplated thereunder, and to agree to such variation, amendments or waiver or matters relating thereto as are, in the opinion of such Director, in the interest of the Company and the shareholders as a whole.
|
| 2025-04-15 |
详情>>
业绩披露：
2024年年报每股收益-0.54元,归母净利润-19.67亿元,同比去年增长9.63%
|
| 2025-04-15 |
详情>>
业绩披露：
2022年年报每股收益-0.73元,归母净利润-26.58亿元,同比去年增长-67.32%
|
| 2024-11-29 |
股东大会：
将于2024-12-31召开股东大会
会议内容 ▼▲
- 1.The terms of the 2024 Kingsoft Framework Agreement entered into by the Company and Kingsoft Corporation on November 19, 2024 and the cloud services contemplated thereunder (including the proposed annual caps for the three years ending December 31, 2027) be and hereby approved and confirmed.
2.The terms of the 2024 Xiaomi Framework Agreement entered into by the Company and Xiaomi on November 19, 2024 and the transactions contemplated thereunder (including the proposed annual caps for the three years ending December 31, 2027) be and hereby approved and confirmed.
3.Any one executive Director be and is hereby authorized to (i) determine the relevant commercial terms arising from the 2024 Kingsoft Framework Agreement and the 2024 Xiaomi Framework Agreement, (ii) sign or execute such other documents or supplement agreements or deeds in respect of the 2024 Kingsoft Framework Agreement and the 2024 Xiaomi Framework Agreement on behalf the Company, and (iii) do all such things and take all such actions as he may consider necessary or desirable for the purpose of giving effect to the 2024 Kingsoft Framework Agreement and the 2024 Xiaomi Framework Agreement and completing relevant transactions.
|
| 2024-11-19 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.49元,归母净利润-17.7亿元,同比去年增长6.47%
|
| 2024-08-20 |
详情>>
业绩披露：
2024年中报每股收益-0.2元,归母净利润-7.13亿元,同比去年增长35.59%
|
| 2024-05-22 |
股东大会：
将于2024-06-28召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements of the Company for the year ended December 31, 2023 and the reports of the Directors and independent auditor thereon.
2.To re-elect Mr. Feng Honghua as a non-executive Director.
3.To authorize the Board to fix the remuneration of the Directors.
4.To re-appoint Ernst & Young as auditor of the Company to hold office until the conclusion of the next annual general meeting of the Company and to authorize the audit committee of the Board to fix their remuneration for the year ending December 31, 2024.
5.To consider and, if thought fit, pass with or without amendments, the following resolution as an ordinary resolution: (a)subject to paragraph (c) below, a general unconditional mandate be and is hereby generally and unconditionally given to the Directors during the Relevant Period (as defined in paragraph (d) below) to exercise all the powers of the Company to allot, issue and deal with additional Shares or securities convertible into Shares, or options, warrants or similar rights to subscribe for Shares or such convertible securities of the Company (other than issuance of options, warrants or similar rights to subscribe for additional Shares or securities convertible into Shares for cash consideration) and to make or grant offers, agreements or options (including any warrants, bonds, notes and debentures conferring any rights to subscribe for or otherwise receive Shares) and to sell and/or transfer Shares out of treasury that are held as treasury shares that would or might require the exercise of such powers; (b)the mandate in paragraph (a) above shall be in addition to any other authorization given to the Directors and shall authorize the Directors to make or grant offers, agreements, and/or options during the Relevant Period that would or might require the exercise of such powers after the end of the Relevant Period; (c)the total number of Shares allotted or agreed conditionally or unconditionally to be allotted and issued, and treasury shares sold and/or transferred or agreed conditionally or unconditionally to be sold and/or transferred (whether pursuant to options or otherwise) in paragraph (a) above, otherwise than pursuant to: (i)a Rights Issue (as defined in paragraph (d) below); (ii)the grant or exercise of any options under any share option scheme of the Company or any other option scheme or similar arrangements for the time being adopted for the grant or issue to the Directors, officers, and/or employee of the Company and/or any of its subsidiaries and/or other eligible participants specified thereunder of options to subscribe for Shares or rights to acquire Shares; (iii)the vesting or exercise of restricted shares and RSUs granted or to be granted (if and where applicable) pursuant to the 2013 Share Award Scheme, the 2021 Share Incentive Plan or any other share incentive scheme or similar arrangements as adopted from time to time; (iv)any scrip dividend scheme or similar arrangement providing for the allotment of Shares (including the sale and/or transfer of any Shares out of treasury and are held as treasury shares) in lieu of the whole or part of a dividend on Shares in accordance with the articles of association of the Company; and (v)a specific authority granted by the Shareholders in general meeting;
shall not exceed 20% of the total number of issued shares (excluding any treasury shares, if any) of the Company as at the date of passing of this resolution (such total number to be subject to adjustment in the case of any consolidation or subdivision of any of the Shares into a smaller or larger number of Shares respectively after the passing of this resolution) and the said mandate shall be limited accordingly; and (d)for the purposes of this resolution: “Relevant Period” means the period from the passing of this resolution until whichever is the earliest of: (i)the conclusion of the next annual general meeting of the Company; (ii)the expiration of the period within which the next annual general meeting of the Company is required by the articles of association of the Company or any applicable laws to be held; and (iii)the date on which the authority set out in this resolution is revoked or varied by an ordinary resolution of the shareholders in general meeting. “Rights Issue” means an offer of Shares of the Company, or an offer or issue of warrants, options or other securities giving rights to subscribe for Shares of the Company, open for a period fixed by the Directors to holders of Shares of the Company whose names appear on the register of members of the Company on a fixed record date in proportion to their then holdings of such Shares of the Company (subject to such exclusions or other arrangements as the directors may deem necessary or expedient in relation to fractional entitlements or having regard to any restrictions or obligations under the laws of, or the requirements of any recognized regulatory body or any stock exchange in, any territory applicable to the Company).”
6.To consider and, if thought fit, pass with or without amendments, the following resolution as an ordinary resolution: (a)a general unconditional mandate be and is hereby given to the Directors during the Relevant Period (as defined in paragraph (b) below) to exercise all the powers of the Company to purchase its own Shares and/or ADSs on the Hong Kong Stock Exchange or on any other stock exchange on which the securities of the Company are or may be listed and which is recognized by the SFC and the Hong Kong Stock Exchange for this purpose, respectively, provided that the total number of Shares and/or ADSs of the Company that may be purchased pursuant to this mandate shall not exceed 10% of the total number of issued Shares (excluding any treasury shares, if any) of the Company as of the date of passing of this resolution (such total number to be subject to adjustment in the case of any consolidation or subdivision of any of the Shares into a smaller or larger number of Shares respectively after the passing of this resolution) and the said mandate shall be limited accordingly; and (b)for the purposes of this resolution:
“Relevant Period” means the period from the passing of this resolution until whichever is the earliest of: (i)the conclusion of the next annual general meeting of the Company; (ii)the expiration of the period within which the next annual general meeting of the Company is required by the articles of association of the Company or any applicable laws to be held; and (iii)the date on which the authority set out in this resolution is revoked or varied by an ordinary resolution of the shareholders in general meeting.”
7.To consider and, if thought fit, pass with or without amendments, the following resolution as an ordinary resolution: “THAT conditional upon the passing of resolutions no. 5 and no. 6 of this notice, the general mandate referred to in the resolution no. 5 of this notice be and is hereby extended by the addition to the aggregate number of (i) Shares and/or ADSs that may be allotted and issued or agreed conditionally or unconditionally to be allotted and issued, and (ii) any Shares out of treasury that are held as treasury shares that may be sold and/or transferred or agreed conditionally or unconditionally to be sold and/or transferred by the Directors pursuant to such general mandate of the number of Shares and/or Shares underlying the ADSs repurchased by the Company pursuant to the mandate referred to in the resolution no. 5 of this notice, provided that such amount shall not exceed 10% of the total number of issued Shares (excluding any treasury shares, if any) of the Company as at the date of the passing of this resolution (such total number to be subject to adjustment in the case of any consolidation or subdivision of any of the Shares into a smaller or larger number of Shares respectively after the passing of this resolution).”
|
| 2024-05-22 |
详情>>
业绩披露：
2024年一季报每股收益-0.1元,归母净利润-3.59亿元,同比去年增长-51.83%
|
| 2024-04-30 |
详情>>
业绩披露：
2023年年报每股收益-0.61元,归母净利润-21.76亿元,同比去年增长18.13%
|
| 2024-01-11 |
股东大会：
将于2024-02-08召开股东大会
会议内容 ▼▲
- 1.THAT the terms of Secured Loan Facility under the Loan Facility Framework Agreement entered into by the Company and Kingsoft Corporation on December 4, 2023, and the proposed Annual Caps be and hereby approved and confirmed.
2.THAT any one executive director of the Company be and is hereby authorized to(i) determine the relevant commercial terms arising from the Loan Facility Framework Agreement in respect of Secured Loan Facility, (ii) sign or execute such other documents or supplement agreements or deeds in respect of the Secured Loan Facility on behalf the Company, (iii) do all such things and take all such actions as he may consider necessary or desirable for the purpose of giving effect to the Loan Facility Framework Agreement in respect of the Secured Loan Facility and completing relevant transactions.
|
| 2023-11-21 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.53元,归母净利润-18.92亿元,同比去年增长11.96%
|
| 2023-06-01 |
股东大会：
将于2023-06-30召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the audited consolidated financial statements of the Company for the year ended December 31, 2022 and the reports of the directors of the Company (the “Director(s)”) and independent auditor thereon.
2.To re-elect Mr. He Haijian as an executive Director.
3.To re-elect Dr. Qiu Ruiheng as a non-executive Director.
4.To re-elect Ms. Qu Jingyuan as an independent non-executive Director.
5.To authorize the board of directors of the Company (the “Board”) to fix the remuneration of the Directors of the Company.
6.To re-appoint Ernst & Young as auditor of the Company to hold office until the conclusion of the next annual general meeting of the Company and to authorize the audit committee of the Board to fix their remuneration for the year ending December 31, 2023.
7.To consider and, if thought fit, pass with or without amendments, the following resolution as an ordinary resolution:“THAT:
(a)subject to paragraph (c) below, a general unconditional mandate be and is hereby generally and unconditionally given to the Directors during the Relevant Period (as defined in paragraph (d) below) to exercise all the powers of the Company to allot, issue and deal with additional Shares or securities convertible into Shares, or options, warrants or similar rights to subscribe for Shares or such convertible securities of the Company (other than issuance of options, warrants or similar rights to subscribe for additional Shares or securities convertible into Shares for cash consideration) and to make or grant offers, agreements or options (including any warrants, bonds, notes and debentures conferring any rights to subscribe for or otherwise receive Shares) that would or might require the exercise of such powers;
(b)the mandate in paragraph (a) above shall be in addition to any other authorization given to the Directors and shall authorize the Directors to make or grant offers, agreements, and/or options during the Relevant Period that would or might require the exercise of such powers after the end of the Relevant Period;
(c)the total number of Shares allotted or agreed conditionally or unconditionally to be allotted and issued (whether pursuant to options or otherwise) in paragraph (a) above, otherwise than pursuant to:(i)a Rights Issue (as defined in paragraph (d) below);(ii)the grant or exercise of any options under any share option scheme of the Company or any other option scheme or similar arrangements for the time being adopted for the grant or issue to the Directors, officers, and/or employee of the Company and/or any of its subsidiaries and/or other eligible participants specified thereunder of options to subscribe for Shares or rights to acquire Shares;(iii)the vesting or exercise of restricted shares and restricted share units granted or to be granted pursuant to the 2013 Share Award Scheme, the 2021 Share Incentive Plan or any other share incentive scheme or similar arrangements as adopted from time to time;(iv)any scrip dividend scheme or similar arrangement providing for the allotment of Shares in lieu of the whole or part of a dividend on Shares in accordance with the articles of association of the Company;(v)a specific authority granted by the Shareholders of the Company in general meeting;shall not exceed 20% of the total number of issued shares of the Company as at the date of passing of this resolution (such total number to be subject to adjustment in the case of any consolidation or subdivision of any of the Shares into a smaller or larger number of Shares respectively after the passing of this resolution) and the said mandate shall be limited accordingly;
(d)for the purposes of this resolution:
“Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:(i)the conclusion of the next annual general meeting of the Company;(ii)the expiration of the period within which the next annual general meeting of the Company is required by the articles of association of the Company or any applicable laws to be held;(iii)the date on which the authority set out in this resolution is revoked or varied by an ordinary resolution of the shareholders in general meeting.
“Rights Issue” means an offer of Shares of the Company, or an offer or issue of warrants, options or other securities giving rights to subscribe for Shares of the Company, open for a period fixed by the Directors to holders of Shares of the Company whose names appear on the register of members of the Company on a fixed record date in proportion to their then holdings of such Shares of the Company (subject to such exclusions or other arrangements as the directors may deem necessary or expedient in relation to fractional entitlements or having regard to any restrictions or obligations under the laws of, or the requirements of any recognized regulatory body or any stock exchange in, any territory applicable to the Company).”
8.To consider and, if thought fit, pass with or without amendments, the following resolution as an ordinary resolution:“THAT:
(a)a general unconditional mandate be and is hereby given to the Directors during the Relevant Period (as defined in paragraph (b) below) to exercise all the powers of the Company to purchase its own Shares and/or ADSs on the Stock Exchange or on any other stock exchange on which the securities of the Company are or may be listed and which is recognized by the SFC and the Stock Exchange for this purpose, respectively, provided that the total number of Shares and/or ADSs of the Company that may be purchased pursuant to this mandate shall not exceed 10% of the total number of issued Shares of the Company as of the date of passing of this resolution (such total number to be subject to adjustment in the case of any consolidation or subdivision of any of the Shares into a smaller or larger number of Shares respectively after the passing of this resolution) and the said mandate shall be limited accordingly;
(b)for the purposes of this resolution:
“Relevant Period” means the period from the passing of this resolution until whichever is the earliest of:(i)the conclusion of the next annual general meeting of the Company;(ii)the expiration of the period within which the next annual general meeting of the Company is required by the articles of association of the Company or any applicable laws to be held;(iii)the date on which the authority set out in this resolution is revoked or varied by an ordinary resolution of the shareholders in general meeting.”
9.To consider and, if thought fit, pass with or without amendments, the following resolution as an ordinary resolution:
“THAT conditional upon the passing of resolutions 7 and 8 of this notice, the general mandate referred to in the resolution 7 of this notice be and is hereby extended by the addition to the aggregate number of Shares and/or ADSs that may be allotted and issued or agreed conditionally or unconditionally to be allotted and issued by the Directors pursuant to such general mandate of the number of Shares and/or Shares underlying the ADSs repurchased by the Company pursuant to the mandate referred to in the resolution 8 of this notice, provided that such amount shall not exceed 10% of the total number of issued Shares of the Company as at the date of the passing of this resolution (such total number to be subject to adjustment in the case of any consolidation or subdivision of any of the Shares into a smaller or larger number of Shares respectively after the passing of this resolution).”
|
| 2022-11-25 |
股东大会：
将于2022-12-29召开股东大会
会议内容 ▼▲
- 1.As a special resolution, THAT, the existing Amended and Restated Memorandum of Association and Articles of Association of the Company be amended and restated by the deletion in their entirety and by the substitution in their place of the Second Amended and Restated Memorandum of Association and Articles of Association in the form as attached hereto as Appendix I, conditional upon and with effect from the consummation of the Company’s proposed listing (the “Listing”) on The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”).
2.As a special resolution, THAT, the name of the Company be changed from Kingsoft Cloud Holdings Limited to Kingsoft Cloud Holdings Limited 金山云控股有限公司 by adoption of the dual Chinese name 金山云控股有限公司, which will be reflected in the Proposed M&AA Amendment.
3.As an ordinary resolution, THAT, conditional upon the Listing,
(a)subject to paragraph (c) below, a general unconditional mandate (the “Issue Mandate”) be and is hereby given to the directors of the Company (the “Directors”) during the Relevant Period (as defined in paragraph (d) below) to exercise all the powers of the Company to allot, issue, and deal with additional Ordinary Shares or securities convertible into Ordinary Shares, or options, warrants or similar rights to subscribe for Ordinary Shares or such convertible securities of the Company (other than issuance of options, warrants or similar rights to subscribe for additional Ordinary Shares or securities convertible into Ordinary Shares for cash consideration) and to make or grant offers, agreements, or options (including any warrants, bonds, notes, and debentures conferring any rights to subscribe for or otherwise receive Ordinary Shares) that would or might require the exercise of such powers;(b)the mandate in paragraph (a) above shall be in addition to any other authorization given to the Directors and shall authorize the Directors to make or grant offers, agreements and/or options during the Relevant Period that would or might require the exercise of such powers after the end of the Relevant Period;(c)the total number of Ordinary Shares allotted or agreed conditionally or unconditionally to be allotted and issued (whether pursuant to options or otherwise) in paragraph (a) above, otherwise than pursuant to:(i)a Rights Issue (as defined in paragraph (d) below);(ii)the grant or exercise of any options under any share option scheme of the Company or any other option, scheme or similar arrangements for the time being adopted for the grant or issue to the directors, officers and/or employee of the Company and/or any of its subsidiaries and/or other eligible participants specified thereunder of options to subscribe for Ordinary Shares or rights to acquire Ordinary Shares;(iii)the vesting of restricted shares and restricted share units granted or to be granted pursuant to the share incentive plan of the Company;(iv)any scrip dividend or similar arrangement providing for the allotment and issue of Shares in lieu of the whole or part of a dividend on Shares of the Company in accordance with the articles of association of the Company;(v)a specific authority granted by the shareholders of the Company in general meeting,shall not exceed 20% of the total number of issued shares of the Company immediately following completion of the Listing;
(d)for the purposes of this resolution:“Relevant Period” means the period from the passing of this resolution until the earliest of:(i)the conclusion of the next annual general meeting of the Company;(ii)the expiration of the period within which the next annual general meeting of the Company is required to be held by the articles of association of the Company or any applicable laws;(iii)the date on which the authority set out in this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting;“Rights Issue” means an offer of shares of the Company, or an offer or issue of warrants, options or other securities giving rights to subscribe for shares of the Company, open for a period fixed by the Directors to holders of Shares of the Company whose names appear on the register of members of the Company on a fixed record date in proportion to their then holdings of such shares of the Company (subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractional entitlements or having regard to any restrictions or obligations under the laws of, or the requirements of any recognized regulatory body or any stock exchange in, any territory applicable to the Company).
4.As an ordinary resolution, THAT, conditional upon the Listing,(a)a general unconditional mandate (the “Repurchase Mandate”) be and is hereby given to the Directors of the Company during the Relevant Period (as defined in paragraph (b) below) to exercise all the powers of the Company to purchase its own shares on the Hong Kong Stock Exchange or on any other stock exchange on which the securities of the Company may be listed and which is recognized by the Securities and Futures Commission of Hong Kong and the Hong Kong Stock Exchange for this purpose, provided that the total number of shares of the Company which may be purchased pursuant to this mandate shall not exceed 10% of the total number of issued shares of the Company immediately following completion of the Listing;(b)for the purposes of this resolution:“Relevant Period” means the period from the passing of this resolution until the earliest of:(i)the conclusion of the next annual general meeting of the Company;(ii)the expiration of the period within which the next annual general meeting of the Company is required to be held by the articles of association of the Company or any applicable laws;(iii)the date on which the authority set out in this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting;
5.As an ordinary resolution, THAT, conditional upon the passing of resolutions in general meeting of the Company to approve the Issuance Mandate and the Repurchase Mandate and conditional upon the Listing, an extension of the Issuance Mandate by the addition to the aggregate number of shares that may be allotted and issued or agreed conditionally or unconditionally to be allotted and issued by the Directors pursuant to the Issuance Mandate of the number of shares repurchased by the Company pursuant to the Repurchase Mandate, provided that such amount shall not exceed 10% of the total number of issued shares of the Company immediately following completion of the Listing, be approved.
6.As an ordinary resolution, THAT, the authorization to each of the Directors or the registered office provider of the Company to take any and all action that might be necessary to effect the foregoing resolutions and make all necessary filings at the Cayman Registry as such Director or the registered office provider of the Company, in his, her or its absolute discretion, thinks fit.
|
| 2022-03-15 |
复牌提示：
2022-03-14 09:53:07 停牌，复牌日期 2022-03-14 09:58:07
|
| 2021-11-05 |
股东大会：
将于2021-12-17召开股东大会
会议内容 ▼▲
- 1.To elect Mr. Hangjun Ye as a director of the Company pursuant to paragraph 87(3) of the Amended and Restated Memorandum and Articles of Association.
2.To increase the authorized share capital of the Company from US$4,000,000.00 divided into 4,000,000,000 ordinary shares with par value of US$0.001 each to US$40,000,000.00 divided into 40,000,000,000 ordinary shares with par value of US$0.001 each by creation of an additional 36,000,000,000 authorized but unissued ordinary shares with par value of US$0.001 each, and the registered office provider of the Company is instructed to make all necessary filings accordingly.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|